Argenx
ARGX
#527
Rank
โ‚ฌ37.35 B
Marketcap
622,78ย โ‚ฌ
Share price
-2.92%
Change (1 day)
79.17%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚ฌ37.35 Billion

As of January 2025 Argenx has a market cap of โ‚ฌ37.35 Billion. This makes Argenx the world's 527th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ37.35 B3.79%
2024โ‚ฌ35.98 B76.3%
2023โ‚ฌ20.41 B4.48%
2022โ‚ฌ19.53 B20.32%
2021โ‚ฌ16.23 B42.44%
2020โ‚ฌ11.39 B85.66%
2019โ‚ฌ6.14 B100.34%
2018โ‚ฌ3.06 B83.42%
2017โ‚ฌ1.67 B
2014โ‚ฌ0.11 B

End of Day market cap according to different sources

On Jan 16th, 2025 the market cap of Argenx was reported to be:

โ‚ฌ38.69 Billion
by Yahoo Finance info icon info icon
โ‚ฌ38.69 Billion
by CompaniesMarketCap info icon info icon
โ‚ฌ37.97 Billion
by Nasdaq info icon info icon